Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meixiao Long

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2006
T-bet down-modulation in tolerized Th1 effector CD4 cells confers a TCR-distal signaling defect that selectively impairs IFN-gamma expressionMeixiao Long, Aaron M Slaiby, Adam T Hagymasi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
In vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization: implications for adoptive immunotherapyMarianne A Mihalyo, Amy D H Doody, Jeremy P McAleer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2007
Histone acetylation at the Ifng promoter in tolerized CD4 cells is associated with increased IFN-gamma expression during subsequent immunization to the same antigenMeixiao Long, Aaron M Slaiby, Shuang Wu, et al.
Nature Communications|June 18, 2024
Siglec-6 as a therapeutic target for cell migration and adhesion in chronic lymphocytic leukemiaJessica Nunes, Rakeb Tafesse, Charlene Mao, et al.
Nature|August 27, 2010
IkappaBbeta acts to inhibit and activate gene expression during the inflammatory responsePing Rao, Mathew S Hayden, Meixiao Long, et al.
Plos One|February 9, 2013
The kinase PDK1 is essential for B-cell receptor mediated survival signalingSung-Gyoo Park, Meixiao Long, Jung-Ah Kang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2008
Self-antigen prevents CD8 T cell effector differentiation by CD134 and CD137 dual costimulationSuman Bandyopadhyay, Meixiao Long, Harry Z Qui, et al.
Cancer Research|November 9, 2021
Systematic Pan-Cancer Characterization of Nuclear Receptors Identifies Potential Cancer Biomarkers and Therapeutic TargetsJunjie Jiang, Jiao Yuan, Zhongyi Hu, et al.
The Journal of Clinical Investigation|November 21, 2018
PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppressionShuai Dong, Bonnie K Harrington, Eileen Y Hu, et al.
Haematologica|May 17, 2020
Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemiaNyla A Heerema, Natarajan Muthusamy, Qiuhong Zhao, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2006
T-bet down-modulation in tolerized Th1 effector CD4 cells confers a TCR-distal signaling defect that selectively impairs IFN-gamma expressionMeixiao Long, Aaron M Slaiby, Adam T Hagymasi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
In vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization: implications for adoptive immunotherapyMarianne A Mihalyo, Amy D H Doody, Jeremy P McAleer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2007
Histone acetylation at the Ifng promoter in tolerized CD4 cells is associated with increased IFN-gamma expression during subsequent immunization to the same antigenMeixiao Long, Aaron M Slaiby, Shuang Wu, et al.
Nature Communications|June 18, 2024
Siglec-6 as a therapeutic target for cell migration and adhesion in chronic lymphocytic leukemiaJessica Nunes, Rakeb Tafesse, Charlene Mao, et al.
Nature|August 27, 2010
IkappaBbeta acts to inhibit and activate gene expression during the inflammatory responsePing Rao, Mathew S Hayden, Meixiao Long, et al.
Plos One|February 9, 2013
The kinase PDK1 is essential for B-cell receptor mediated survival signalingSung-Gyoo Park, Meixiao Long, Jung-Ah Kang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2008
Self-antigen prevents CD8 T cell effector differentiation by CD134 and CD137 dual costimulationSuman Bandyopadhyay, Meixiao Long, Harry Z Qui, et al.
Cancer Research|November 9, 2021
Systematic Pan-Cancer Characterization of Nuclear Receptors Identifies Potential Cancer Biomarkers and Therapeutic TargetsJunjie Jiang, Jiao Yuan, Zhongyi Hu, et al.
The Journal of Clinical Investigation|November 21, 2018
PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppressionShuai Dong, Bonnie K Harrington, Eileen Y Hu, et al.
Haematologica|May 17, 2020
Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemiaNyla A Heerema, Natarajan Muthusamy, Qiuhong Zhao, et al.
Pageof 4